tiprankstipranks
Advertisement
Advertisement

CRNX Stock Latest News

Crinetics Pharma Bets Big on Palsonify Launch
Company AnnouncementsCrinetics Pharma Bets Big on Palsonify Launch
19h ago
CRNX
3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
PremiumMarket News
3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
5d ago
CRNX
LEGN
Crinetics price target lowered to $88 from $89 at Evercore ISI
PremiumThe Fly
Crinetics price target lowered to $88 from $89 at Evercore ISI
6d ago
CRNX
Crinetics price target lowered to $84 from $87 at Oppenheimer
PremiumThe Fly
Crinetics price target lowered to $84 from $87 at Oppenheimer
9d ago
CRNX
Crinetics Pharma Earnings Call Highlights Palsonify Momentum
PremiumCompany Announcements
Crinetics Pharma Earnings Call Highlights Palsonify Momentum
12d ago
CRNX
Crinetics price target lowered to $95 from $97 at Citizens
PremiumThe FlyCrinetics price target lowered to $95 from $97 at Citizens
13d ago
CRNX
Crinetics reports Q1 EPS ($1.23), consensus ($1.24)
Premium
The Fly
Crinetics reports Q1 EPS ($1.23), consensus ($1.24)
13d ago
CRNX
Analyst Maintains Buy on Palsonify Amid Strong Global Growth Prospects Despite Trimmed Price Target to $90
Premium
Ratings
Analyst Maintains Buy on Palsonify Amid Strong Global Growth Prospects Despite Trimmed Price Target to $90
23d ago
CRNX
Crinetics price target raised to $97 from $96 at Citizens
PremiumThe Fly
Crinetics price target raised to $97 from $96 at Citizens
23d ago
CRNX
Crinetics’ Palsonify approved by European Commission for acromegaly
PremiumThe Fly
Crinetics’ Palsonify approved by European Commission for acromegaly
23d ago
CRNX
ALX Oncology appoints Jeff Knight as chief development, operating officer
PremiumThe Fly
ALX Oncology appoints Jeff Knight as chief development, operating officer
1M ago
ALXO
CRNX
Crinetics submits Palsonify marketing authorization application to ANVISA
PremiumThe Fly
Crinetics submits Palsonify marketing authorization application to ANVISA
2M ago
CRNX
Crinetics Advances Atumelnant: Phase 1 Study Completion Sets Up Next Clinical Catalyst for CRNX
PremiumCompany AnnouncementsCrinetics Advances Atumelnant: Phase 1 Study Completion Sets Up Next Clinical Catalyst for CRNX
2M ago
CRNX
Crinetics Pharma Earnings Call: Launch, Pipeline, Runway
Premium
Company Announcements
Crinetics Pharma Earnings Call: Launch, Pipeline, Runway
3M ago
CRNX
Crinetics price target lowered to $96 from $105 at Citizens
Premium
The Fly
Crinetics price target lowered to $96 from $105 at Citizens
3M ago
CRNX
Crinetics price target lowered to $83 from $84 at Stifel
PremiumThe Fly
Crinetics price target lowered to $83 from $84 at Stifel
3M ago
CRNX
Crinetics reports Q4 EPS ($1.29), consensus ($1.37)
PremiumThe Fly
Crinetics reports Q4 EPS ($1.29), consensus ($1.37)
3M ago
CRNX
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
PremiumMarket News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
3M ago
BIB
CRBU
Crinetics price target raised to $84 from $75 at Stifel
PremiumThe Fly
Crinetics price target raised to $84 from $75 at Stifel
4M ago
CRNX
Crinetics doses first patient in BALANCE-CAH trial
PremiumThe FlyCrinetics doses first patient in BALANCE-CAH trial
4M ago
CRNX
‘Markets Climb Wall-of-Worry’: Oppenheimer Sees Resilience Driving 2026 and Suggests 2 Stocks to Buy
Premium
Stock Analysis & Ideas
‘Markets Climb Wall-of-Worry’: Oppenheimer Sees Resilience Driving 2026 and Suggests 2 Stocks to Buy
4M ago
AMPX
CRNX
Crinetics Highlights Breakout Year and Strong Endocrinology Pipeline
Premium
Company Announcements
Crinetics Highlights Breakout Year and Strong Endocrinology Pipeline
4M ago
8K
CRNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >